Investors & Partners  

Investors

schooner capital_logo

Cartesian has been funded since inception by a group of investors that includes Schooner Capital, a Boston-based investment firm founded in 1971. With a significant focus on biotechnology, medical device and healthcare services, Schooner approaches all investments with a long-term perspective, enabling Cartesian to focus on product development. For more information, visit schoonercapital.com

Partners

We welcome strategic collaborations that expand the therapeutic applications of our technology platform in the following areas:

Autoimmune
Cardiovascular
Oncology
Respiratory

Contact Us

If you are interested in exploring a partnership with us for these areas, please contact us at info@cartesiantx.com.